St. Luke's Cancer Institute
Idaho State University College of Pharmacy
Boise, Idaho
Dr. Robert Mancini is the BMT/Heme Pharmacy Program Coordinator and PGY2 Oncology Pharmacy Residency Director at St. Luke's Cancer Institute in Boise, ID. He also serves as Clinical Adjunct Instructor of Oncology at Idaho State University College of Pharmacy. Dr. Mancini received his PharmD from the University of California, San Diego, his PGY1 Pharmacy Residency at St. Luke's Regional Medical Center and PGY2 Oncology Pharmacy Residency at St. Luke's Cancer Institute. Dr. Mancini has served in many roles during his time at SLCI including as the lead for the Oral Chemotherapy Program, the NCCCP/Supportive Care Pharmacist, Lead for the Fruitland Infusion Center/Clinic and now his current role listed above. Dr. Mancini has served on multiple commitees for ASTCT, HOPA, ISCO, & ISHP and has published and presented on numerous topics related to oncology. Most recently, he is the author on the Cancer Screening & Prevention BCOP review chapter for HOPA and been awarded the clinical excellence award from ASTCT for his work in establishing the the allogeneic transplant program at St. Luke's. Dr. Mancini was also selected as a fellow of the Hematology/Oncology Pharmacist Association (FHOPA) in 2020.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thursday, April 28, 2022
3:25 PM – 4:00 PM
Thursday, April 28, 2022
4:00 PM – 4:10 PM
Thursday, August 11, 2022
3:10 PM – 3:45 PM
Thursday, August 11, 2022
3:45 PM – 3:55 PM
Thursday, November 17, 2022
3:10 PM – 3:45 PM
Thursday, November 17, 2022
3:45 PM – 3:55 PM